These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 28042766)

  • 1. Insights into the Regulation of Yap/Taz from Cellular Systems and Mouse Models.
    Du W; Du W; Wan M; Zhou X; Xu X; Zheng L
    Curr Stem Cell Res Ther; 2018; 13(1):16-25. PubMed ID: 28042766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.
    Plouffe SW; Lin KC; Moore JL; Tan FE; Ma S; Ye Z; Qiu Y; Ren B; Guan KL
    J Biol Chem; 2018 Jul; 293(28):11230-11240. PubMed ID: 29802201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
    Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL
    Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP and TAZ regulate skin wound healing.
    Lee MJ; Byun MR; Furutani-Seiki M; Hong JH; Jung HS
    J Invest Dermatol; 2014 Feb; 134(2):518-525. PubMed ID: 24108406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?
    Shreberk-Shaked M; Oren M
    Mol Oncol; 2019 Jun; 13(6):1335-1341. PubMed ID: 31050214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway.
    Wang Y; Cao W; Cui J; Yu Y; Zhao Y; Shi J; Wu J; Xia Z; Yu B; Liu J
    Cell Physiol Biochem; 2018; 51(2):842-853. PubMed ID: 30466081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7.
    Chaulk SG; Lattanzi VJ; Hiemer SE; Fahlman RP; Varelas X
    J Biol Chem; 2014 Jan; 289(4):1886-91. PubMed ID: 24324261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
    Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
    J Cell Sci; 2024 May; 137(10):. PubMed ID: 38813860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
    Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
    J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of YAP, TAZ and HSP90 in contact guidance and intercellular junction formation in corneal epithelial cells.
    Raghunathan VK; Dreier B; Morgan JT; Tuyen BC; Rose BW; Reilly CM; Russell P; Murphy CJ
    PLoS One; 2014; 9(10):e109811. PubMed ID: 25290150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
    Nishina H
    Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
    Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
    Kim M; Kim T; Johnson RL; Lim DS
    Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of differentiation of mesenchymal stem cells by the Hippo pathway effectors TAZ/YAP].
    Men T; Piao SH; Teng CB
    Yi Chuan; 2013 Nov; 35(11):1283-90. PubMed ID: 24579311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number.
    Lavado A; Park JY; Paré J; Finkelstein D; Pan H; Xu B; Fan Y; Kumar RP; Neale G; Kwak YD; McKinnon PJ; Johnson RL; Cao X
    Dev Cell; 2018 Dec; 47(5):576-591.e8. PubMed ID: 30523785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-canonical repressor function of JUN restrains YAP activity and liver cancer growth.
    Kurlishchuk Y; Cindric Vranesic A; Jessen M; Kipping A; Ritter C; Kim K; Cramer P; von Eyss B
    EMBO J; 2024 Oct; 43(20):4578-4603. PubMed ID: 39210147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.